The graph shows the results of our forecasting system for MRK. You can view historical price data with markers indicating where our system has signaled and where projected targets have been achieved. This demonstrates how our system's forecasts have performed in real market conditions.
We do not display all achieved goals on the graph; detailed information is available in the corresponding section on this page.
The graph is interactive. Hover over target icons to see when the forecast was created.
Show news about the achieved forecast.
Signal Date | Signal Price | Date Reached | Price Reached | Profit | Direction |
---|---|---|---|---|---|
2022-04-27 | 75.94 $ | 2022-11-25 | 98.29 $ | 29.43% | |
2022-05-05 | 79.18 $ | 2022-12-27 | 103.2 $ | 30.33% | |
2022-05-06 | 79.52 $ | 2022-12-27 | 103.2 $ | 29.77% | |
2022-05-09 | 78.85 $ | 2022-12-27 | 103.2 $ | 30.88% | |
2022-05-10 | 79 $ | 2022-12-27 | 103.2 $ | 30.63% | |
2022-05-11 | 80.24 $ | 2022-12-27 | 103.2 $ | 28.61% | |
2022-05-12 | 81.72 $ | 2022-12-14 | 102.67 $ | 25.64% | |
2022-05-13 | 81.34 $ | 2022-12-14 | 102.67 $ | 26.23% | |
2022-05-16 | 83.06 $ | 2022-12-14 | 102.67 $ | 23.61% | |
2022-05-17 | 83.67 $ | 2022-11-30 | 100.69 $ | 20.34% | |
2022-05-18 | 82.86 $ | 2022-11-28 | 99.16 $ | 19.67% | |
2022-05-25 | 84.35 $ | 2023-01-05 | 104.6 $ | 24.01% | |
2022-06-01 | 82 $ | 2022-11-29 | 99.52 $ | 21.37% | |
2022-06-03 | 80.89 $ | 2022-11-25 | 98.29 $ | 21.51% | |
2022-06-07 | 81.4 $ | 2022-11-30 | 100.69 $ | 23.69% | |
2022-06-08 | 80.5 $ | 2022-11-30 | 100.69 $ | 25.07% | |
2022-06-10 | 78.44 $ | 2022-12-27 | 103.2 $ | 31.57% | |
2022-06-13 | 76.47 $ | 2022-12-27 | 103.2 $ | 34.95% | |
2022-06-14 | 76.65 $ | 2023-04-13 | 107.12 $ | 39.76% | |
2022-06-15 | 76.76 $ | 2023-04-13 | 107.12 $ | 39.55% | |
2022-06-16 | 77 $ | 2023-04-13 | 107.12 $ | 39.12% | |
2022-06-17 | 76.75 $ | 2023-04-13 | 107.12 $ | 39.56% | |
2022-06-21 | 79.85 $ | 2023-04-13 | 107.12 $ | 34.16% | |
2022-06-23 | 83.45 $ | 2023-01-06 | 105.7 $ | 26.67% | |
2022-06-28 | 83.35 $ | 2023-04-13 | 107.12 $ | 28.52% | |
2022-07-07 | 84.37 $ | 2023-05-02 | 109.26 $ | 29.51% | |
2023-07-03 | 106.67 $ | 2024-06-24 | 127.36 $ | 19.39% | |
2023-09-05 | 100.31 $ | 2024-02-01 | 119.58 $ | 19.21% | |
2023-12-26 | 101.84 $ | 2024-01-10 | 112.46 $ | 10.43% | |
2024-12-24 | 96.67 $ | 2025-02-06 | 85.59 $ | 11.46% | |
2024-12-31 | 96.7 $ | 2025-02-06 | 85.59 $ | 11.49% | |
2025-02-25 | 88.87 $ | 2025-04-04 | 79.87 $ | 10.12% | |
2025-02-28 | 89.67 $ | 2025-04-04 | 79.87 $ | 10.92% | |
2025-03-04 | 89.97 $ | 2025-04-10 | 76.03 $ | 15.49% | |
2025-03-07 | 92 $ | 2025-05-14 | 72.03 $ | 21.71% | |
2025-03-11 | 92.08 $ | 2025-05-14 | 72.03 $ | 21.77% | |
2025-03-27 | 85.88 $ | 2025-05-14 | 72.03 $ | 16.13% | |
2025-06-13 | 80.11 $ | 2025-10-01 | 90.13 $ | 12.51% |
Our forecast for the cost of MERCK & CO., INC. (MRK) in December 2024, January 2025, February 2025, March 2025, and April 2025 provides valuable insights for investors looking to earn and diversify their portfolio. By purchasing our forecast, you will gain access to crucial information on the changes in value and dynamics of MRK.
With this information, you can make informed decisions on whether the cost of MRK will rise or fall during these months. This knowledge will enable you to choose a suitable strategy that aligns with your investment goals.
Diversifying your portfolio is essential for minimizing risk and maximizing returns. By staying updated with our forecasts, you can stay ahead of market trends and adjust your investments accordingly. This will help you make strategic decisions that lead to better investment outcomes.
Stay tuned for the release of new forecasts for MRK, ensuring that you have a comprehensive understanding of the entire investment period. Don't miss out on this opportunity to make informed investment decisions and maximize your portfolio's potential.
Merck & Co., Inc. (MRK) has seen a 2.8% increase in its stock price since the last earnings report, but investors are now wondering if this growth can be sustained....
MRK Merck & Co., Inc. has recently received FDA approval to expand the use of its top-selling drug Keytruda. This news has led to positive expectations for the company's future performance....
Merck & Co., Inc. (MRK) has been recognized as one of the top dividend contenders in the market, according to Yahoo Finance....
Merck Co. Inc. (MRK) has emerged as a top pick among investors looking for stable and reliable stocks....
Shareholders that lost money on Merck & Co. Inc. (MRK) are being urged to join a class action against the company....
Merck & Co., Inc., commonly known as Merck, has emerged as one of the most undervalued stocks in the US market, as indicated by leading hedge funds....
Merck & Co. (MRK), one of the leading pharmaceutical companies, has announced the opening of its state-of-the-art $1 billion Next-Generation Vaccine Facility....
Merck & Co., Inc., commonly known as Merck, is a global healthcare company that develops and markets innovative pharmaceutical, vaccine, biologic, and animal health products....
Merck & Co., Inc. (MRK) is set to present its strategic update at the upcoming TD Cowen Healthcare Conference....
Investors of MRK Merck & Co. Inc. have been urged by ROSEN HIGHLY RECOGNIZED INVESTOR COUNSEL to seek legal representation before the critical deadline related to a securities class action....
MOS
THE MOSAIC COMPANY
Materials
AVAX-USD
AVALANCHE USD
Cryptocurrency
HON
HONEYWELL INTERNATIONAL INC.
Industrials
CRM
SALESFORCE, INC.
Technology
KT
KT CORPORATION
Telecommunications
KO
THE COCA-COLA COMPANY
Consumer Staples